Spain's Stat-Diagnostica Closes €25M Series C Financing | GenomeWeb

NEW YORK (GenomeWeb) – Spanish clinical diagnostics firm Stat-Diagnostica said yesterday that it has closed a Series C financing round for €25 million ($28.5 million) to prepare for the 2017 launch of its DiagCore near-patient testing system.

The financing round was led by new investor Gilde Healthcare, with participation from existing investors including Kurma Partners, Ysios Capital, Idinvest Partners, Boehringer Ingelheim Venture Fund, Caixa Capital Risc, and Axis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.